UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043355
Receipt number R000049501
Scientific Title Evaluation of the accuracy of diagnosis by Endocytosopy in SNADET
Date of disclosure of the study information 2021/03/01
Last modified on 2023/09/19 09:59:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the accuracy of diagnosis by Endocytosopy in SNADET

Acronym

Evaluation of the accuracy by Endocytosopy in SNADET

Scientific Title

Evaluation of the accuracy of diagnosis by Endocytosopy in SNADET

Scientific Title:Acronym

Evaluation of the accuracy by Endocytosopy in SNADET

Region

Japan


Condition

Condition

SNADET

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the diagnosis for SNADET by Endocytoscopy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensitivity, specificity, positive predictive value, negative predictive value, and positive predictive value of offline adenoma and cancer diagnosis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled for endoscopic treatment or surgery for SNADET at our hospital

Key exclusion criteria

Cases of residual recurrence after endoscopic treatment
Patients who are allergic to methylene blue
Patients who are difficult to perform Endocyto (difficult to insert endoscope, difficult to observe, etc.) and other patients who are considered difficult to register by the doctor in charge.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Seiichiro
Middle name
Last name Abe

Organization

National Cancer Center Hospital

Division name

Endoscopy Division

Zip code

1040045

Address

5-1-1 Tsukiji, Chuoku, Tokyo

TEL

03-3542-2511

Email

seabe@ncc.go.jp


Public contact

Name of contact person

1st name Mai
Middle name
Last name Ego

Organization

National Cancer Center Hospital

Division name

Endoscopy Division

Zip code

1040045

Address

5-1-1 Tsukiji, Chuoku, Tokyo

TEL

03-3542-2511

Homepage URL


Email

mego@ncc.go.jp


Sponsor or person

Institute

Endoscopy Division, National Cancer Center Hospital

Institute

Department

Personal name



Funding Source

Organization

Endoscopy Division, National Cancer Center Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Endoscopy Division, National Cancer Center Hospital

Address

5-1-1 Tsukiji, Chuoku, Tokyo

Tel

03-3542-2511

Email

03-3542-2511


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 12 Month 02 Day

Date of IRB

2020 Year 12 Month 02 Day

Anticipated trial start date

2021 Year 03 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Evaluation of the accuracy of diagnosis by Endocytosopy in SNADET


Management information

Registered date

2021 Year 02 Month 17 Day

Last modified on

2023 Year 09 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049501